Technology and Data

Timothy Aungst, PharmD; Ravi Patel, PharmD, MBA, MS; and Smit Patel, PharmD, share their insights on the emerging direct-to-patient pharmacy model.

Alongside the global pharma market, OTC supplements are expected to experience over a 6% compound annual growth rate for the next 5-plus years.

Representatives from the American Society of Consultant Pharmacists joined Drug Topics to discuss the day 1 reality of the Medicare Drug Price Negotiation Program.

The current understanding regarding artificial intelligence (AI) in pharmacy curricula is necessary to equip future pharmacists with advanced technological knowledge.

As social media’s growth seemingly has no end in sight, pharmacists must be conscious of its potential risks and benefits when using these platforms for either personal or professional use.

In part 3 of our interview, Jennifer Flynn, CPHRM, flips the script on potential harms in using social media and explores how pharmacists can use it to advance their career.

Jennifer Flynn, CPHRM, joins Drug Topics to discuss the nuances in social media use for pharmacists and the potential risks they can encounter.

Jennifer Flynn, CPHRM, vice president of health care risk management at the Healthcare Provider Service Organization, discusses pharmacists’ roles in patient privacy.

Prateek Bhatia, PhD, discusses barriers to accessing infusion center services and how the pharmacist can alleviate patient challenges.

Study authors explore online purchasing habits for prescription-only and OTC medications.

The NCPDP gathered essential members from the pharmacy community in a roundtable discussion on electronic prior authorizations.

Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, discusses the Touro University California, pharmacist-led Pharm2Home initiative.

In today’s world, the exponential use of technology is gradually becoming commonplace, and pharmacy businesses are expected to keep up with the growing digital landscape.

Nicole Pezzino, PharmD, BCACP, BC-ADM, CDCES, discusses why the underutilization of technology could be hurting pharmacy businesses.

Don Roosan, PharmD, PhD, discusses the ethical implications of AI in pharmacy, focusing on patient safety, transparency, and the importance of human connection in care.

Don Roosan, PharmD, PhD, discusses the changing technology, challenging conventional boundaries of pharmaceutical practice through telepharmacy and artificial intelligence.

With disruptive PBMs rising in the marketplace amid constant calls for lowering drug prices, companies such as WriteWise are positioned to revolutionize the way patients access their pharmacy benefits.

Lissette Logan, PharmD, and Danielle Weaver, PharmD, discuss their use of the PRISM platform for providing contraceptive and family-planning services.

Researchers conduct a proof-of-concept study exploring the feasibility of health information technology interoperability between a medical office and independent pharmacies.

In hospitalized patients with obesity, researchers conduct a study detailing how electronic clinical support helps participants optimize their treatment regimens.

To better understand its potential role in the pharmacy profession, researchers explore artificial intelligence and the ways pharmacists are aware of its growing implementation.

In an exploration of provider reporting and pharmacovigilance, researchers assessed community pharmacists’ knowledge, attitudes, and practices regarding adverse drug reactions.

Gaining insight from Walgreens’ senior director of immunizations, Samantha Picking, PharmD, discusses her company’s innovative approaches to boosting vaccination rates.

Colleges of pharmacy are retooling curricula and faculty skill sets to ensure students are prepared to use the technology of the next decade.

Polypharmacy and potentially inappropriate medications are cited as concerns in older adults who require long-term care, especially for those with comorbidities or at multiple institutions.